What’s Next? A Better Way to Deliver Cancer Treatment - May 16

What’s Next? A Better Way to Deliver Critical Treatments for Cancer, etc., directly into our human-body cells. 

Sturbridge Rotary Club Past-President & CEO of TransCytos, Otto Prohaska Ph.D., and Advisor-Human Therapy Applications, Theresa O’Keefe, Ph.D., will present during the Sturbridge club’s meeting on Tuesday, May 16th at the Publick House historic inn at Sturbridge Common. This presentation also available live via Zoom. Please contact club president Klaus Hachfeld to attend. (cell: 774-922-2030).

TransCytos is a medical device company that has invented Slipstream™, a technology that DOES NOT use viruses to deliver critical medicines to the DNA in patients’ cells. Safe, fast and affordable cell and gene therapies for the cure of cancer, autoimmune, infectious and rare diseases will be developed and delivered to the patients in collaboration with pharma partners. Slipstream™ will make therapies possible at the patients’ bedsides in local hospitals so that these cures can be performed worldwide using the patients’ own cells, WITHOUT the need for chemo, radiation, or viruses.